Chubb Limited
NYSECB has cleared its Q2 earnings hurdle, and the post-print picture is one of measured validation — targets moving higher across the board, the stock holding near $354.80, yet the analyst community declining to upgrade in any meaningful number. The most telling dynamic is the gap between where analysts are setting targets and what ratings they're willing to attach to them. The mean…
CB cost to borrow surges to 0.57%, up 219% over one week, as short interest climbs to 1.13% of float.
CB has cleared its Q2 earnings hurdle, and the post-print picture is one of measured validation — targets moving higher across the board, the stock holding near $354.80, yet the analyst community declining to upgrade…
CB arrives at its Q2 earnings release having recovered sharply from the pre-earnings pullback, with options positioning flipping back toward the bullish end of its recent range. The most notable shift since the July 18…
Snapshot as of 16 Aug 2026
CB heads into Tuesday's Q2 print having bounced back from last week's pullback, with a clearer bullish tilt in options positioning than at any point in the past year. The options market is the most striking data point…
CB enters its July 21 earnings print having given back last week's gains, with the stock off 3.6% this week to $346.22, reversing course even as analysts race to revise targets higher. The gap between analyst optimism…
CB heads into its July 21 earnings print on a strong footing — up 5.4% on the week and 10.1% over the past month — with a flurry of analyst target increases arriving just as the stock touches $359. The most notable…
Options traders are piling into calls on CB at an unprecedented rate. The put-call ratio has dropped to 0.58 — 3.06 standard deviations below its 20-day mean of 0.68. That's the lowest PCR reading in 52 weeks. The…
CB heads into the back half of May in an uncommon spot for a mega-cap insurer — analysts are raising targets, short sellers are pulling back, and the stock is almost exactly where it was a month ago. The most coherent…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CB — free to start on ORTEX.
Sign up for free →Open CB on ORTEX